PRE revenueFY2024$30.62M
- FY YoY
- +40.8%
PRE revenue was $30.62M for fiscal 2024 (ended Dec 31, 2024), up 40.8% from fiscal 2023. It rose in 3 of the last 4 fiscal years.
Prenetics Global Limited (PRE) financials
For fiscal 2024 (ended Dec 31, 2024), Prenetics Global Limited reported $30.62M of revenue and -$46.30M of net income.
- Revenue, FY2024
- $30.62M
- Revenue growth, YoY
- +40.8%
- Net income, FY2024
- -$46.30M
- Net margin
- -151.2%
- Free cash flow, FY2024
- -$29.88M
- EPS, diluted, FY2024
- -$3.71
- Cash
- $52.25M
- P/S
- 8.82
- Market cap
- $270.0M
FY2020FY2024
FY2020FY2024
FY2020FY2024
PRE revenue and earnings growth
PRE net incomeFY2024-$46.30M
PRE net income was -$46.30M for fiscal 2024 (ended Dec 31, 2024), compared with -$62.72M in fiscal 2023.
PRE EPSFY2024-$3.71
PRE diluted EPS was -$3.71 for fiscal 2024 (ended Dec 31, 2024), compared with -$5.58 in fiscal 2023.
PRE free cash flowFY2024-$29.88M
PRE free cash flow was -$29.88M for fiscal 2024 (ended Dec 31, 2024), compared with -$14.11M in fiscal 2023.
Income statement
| Line item | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $30.62M | $21.74M | $13.16M | $12.53M | $65.18M |
| Cost of revenue | $15.22M | $12.91M | $9.55M | $8.93M | $38.83M |
| Gross profit | $15.40M | $8.83M | $3.62M | $3.60M | $26.34M |
| Research and development | $10.92M | $11.66M | $5.99M | $6.39M | $2.78M |
| Operating income | -$48.14M | -$51.91M | -$66.02M | -$56.66M | -$995.1K |
| Interest expense | - | - | $4.20M | $5.24M | $59.6K |
| Pre-tax income | -$57.70M | -$56.67M | -$225.82M | -$216.55M | -$3.90M |
| Income tax | -$7.87M | -$269.0K | -$245.0K | $2.57M | -$1.94M |
| Net income | -$46.30M | -$62.72M | -$190.45M | -$174.01M | -$1.94M |
| EPS, basic | -$3.71 | -$5.58 | -$37.57 | -$178.81 | -$2.25 |
| EPS, diluted | -$3.71 | -$5.58 | -$37.57 | -$178.81 | -$2.25 |
| Diluted shares | 12.5M | 11.2M | 5.1M | 973,134 | 878,450.133 |
Balance sheet
| Line item | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Cash and equivalents | $52.25M | $45.71M | $146.66M | $35.29M | $14.49M |
| Short-term investments | $10.56M | $11.03M | $17.54M | $9.91M | - |
| Receivables | $16.77M | $17.66M | $53.16M | $54.86M | - |
| Inventory | $6.57M | $3.13M | $4.53M | $6.83M | - |
| Current assets | $86.15M | $93.66M | $241.81M | $106.89M | - |
| Goodwill | $37.36M | $29.17M | $33.80M | $3.98M | $3.99M |
| Total assets | $213.57M | $254.17M | $312.13M | $148.51M | - |
| Current liabilities | $36.55M | $39.48M | $57.20M | $58.74M | - |
| Total liabilities | $42.23M | $44.01M | $68.67M | $549.40M | - |
| Shareholders' equity | $170.39M | $206.36M | $243.46M | -$400.89M | $31.01M |
Cash flow
| Line item | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Operating cash flow | -$28.87M | -$13.77M | $14.52M | $13.42M | -$2.88M |
| Capital expenditures | $1.01M | $345.0K | $4.95M | $8.55M | $2.86M |
| Free cash flow | -$29.88M | -$14.11M | $9.57M | $4.87M | -$5.74M |
| Investing cash flow | $38.54M | -$82.95M | -$46.15M | -$22.02M | -$5.97M |
| Financing cash flow | -$3.34M | -$4.70M | $143.32M | $29.32M | $11.84M |
| Stock-based compensation | $7.85M | $10.59M | $31.58M | $22.49M | $1.62M |
Key ratios
| Line item | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Revenue growth, YoY | 40.8% | 65.2% | 5.0% | -80.8% | - |
| Gross margin | 50.3% | 40.6% | 27.5% | 28.7% | 40.4% |
| Operating margin | -157.2% | -238.7% | -501.5% | -452.1% | -1.5% |
| Net margin | -151.2% | -288.5% | -1446.8% | -1388.4% | -3.0% |
| Free cash flow margin | -97.6% | -64.9% | 72.7% | 38.9% | -8.8% |
| Return on equity | -27.2% | -30.4% | -78.2% | - | -6.3% |
| Return on assets | -21.7% | -24.7% | -61.0% | -117.2% | - |
| Current ratio | 2.36 | 2.37 | 4.23 | 1.82 | - |
Source: XBRL data Prenetics Global Limited files with the SEC, latest filing dated Apr 30, 2025 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-15, first reported May 1, 2024.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
PRE peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| PRE | $30.62M | +40.8% | -$46.30M | -151.2% | $270.0M |
| TACO | $11.6K | - | $9.36M | 80937.6% | $382.6M |
| OXSQ | - | - | -$32.87M | - | $105.7M |
| INV | $3.75M | +154.7% | -$120.38M | -3208.4% | $12.0M |
| MLEC | $333.61M | -28.5% | -$111.46M | -33.4% | $1.2M |
PRE FAQ
9 questionsWhat is PRE revenue?
Prenetics Global Limited (PRE) reported $30.62M of revenue for fiscal 2024 (ended Dec 31, 2024). That is up 40.8% from the year before.Is PRE profitable?
No. Prenetics Global Limited reported a net loss of $46.30M for fiscal 2024 (ended Dec 31, 2024).How much cash and debt does PRE have?
Prenetics Global Limited reported $52.25M in cash and cash equivalents on its most recent balance sheet in SEC filings.How fast is PRE revenue growing?
Prenetics Global Limited's revenue changed +40.8% in fiscal 2024, to $30.62M.What is PRE gross margin?
Prenetics Global Limited's gross profit was $15.40M on $30.62M of revenue for fiscal 2024 (ended Dec 31, 2024), a gross margin of 50.3%.What is PRE free cash flow?
Prenetics Global Limited generated -$29.88M of free cash flow for fiscal 2024 (ended Dec 31, 2024), which is operating cash flow of -$28.87M less capital expenditures.What is PRE earnings per share?
Diluted earnings per share were -$3.71 for fiscal 2024 (ended Dec 31, 2024), from SEC filings, restated for any stock split those filings show.When did PRE last report financial results?
The latest statements here come from Prenetics Global Limited's 20-F filed on Apr 30, 2025, covering the period ended Dec 31, 2024.Where does this PRE financial data come from?
Quantisnow builds these statements from the structured XBRL data Prenetics Global Limited files with the SEC. It is provided for information only and is not investment advice.